๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Population screening for colorectal cancer: Comparison between guaiac and immunological faecal occult blood tests

โœ Scribed by Mr M. H. E. Robinson; C. G. Marks; P. A. Farrands; W. M. Thomas; J. D. Hardcastle

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
423 KB
Volume
81
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Faecal occult blood screening for colore
Faecal occult blood screening for colorectal cancer: is it cost-effective?
โœ David K. Whynes; Aileen R. Neilson; Andrew R. Walker; Jack D. Hardcastle ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 105 KB ๐Ÿ‘ 2 views

Recently published evidence from two large-scale clinical trials conducted in England and in Denmark suggests that faecal occult blood screening for colorectal cancer significantly reduces mortality. However, before screening can be advocated as part of national health policy, its cost-effectiveness

Faecal occult blood screening for colore
Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population
โœ Mrs. S. M. Caffarey; C. I. M. Broughton; C. G. Marks ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 256 KB ๐Ÿ‘ 1 views

## colorectal neoplasia in a targeted high-risk population A general practice-based programme was initiated in I987 to identifv individuals at high risk of developing large bowel cancer and ofler them screening of faecal occult blood. In all, 5298 people from 21 general practices in the Guildford

A control trial of faecal occult blood s
A control trial of faecal occult blood screening for colorectal cancer: 2-year results
โœ J. D. Hardcastle; N. C. Armitage; J. Chamberlain; T. W. Balfour; S. S. Amar ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 342 KB ๐Ÿ‘ 2 views

positive tests will have colorectal neoplasia, including 5-10 per cent with cancer". Improvements in specificity using vegetable peroxidase inhibitors, faecal porphyrin assays, or immunochemical tests for blood should be possible. None of these tests will discriminate between bleeding from neoplasti